Why is Rossari Biotech falling/rising?

As of 26-Aug, Rossari Biotech Ltd is experiencing a decline in its stock price, currently at 619.35, reflecting a decrease of 7.6 points or 1.21%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.92% during this period. Additionally, the stock has shown significant underperformance over the past year, with a return of -34.26%, while its profits have decreased by 1%. Despite having a low debt-to-equity ratio and attractive valuation metrics, the stock is trading at a discount compared to its peers, which may not be sufficient to offset the negative sentiment stemming from its flat results in June and consistent underperformance against benchmarks over the last three years.
In the broader market context, Rossari Biotech's short-term performance has been notably worse than the benchmark, with a 1-week return of -3.45% compared to the Sensex's -1.05%. This trend of underperformance is further highlighted by the stock's year-to-date return of -21.37% against the Sensex's positive return of 3.39%. While there has been a rise in investor participation, as indicated by an increase in delivery volume, the overall market sentiment remains cautious due to the company's recent financial results and historical performance, contributing to the stock's downward trajectory.